STOCK TITAN

Azenta Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call and Webcast

Azenta (AZTA) will announce fiscal fourth-quarter and full-year 2026 earnings after the market closes on November 10, 2026.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Azenta (AZTA) will announce fiscal fourth-quarter and full-year 2026 earnings after the market closes on November 10, 2026.

The reporting periods ended September 30, 2026. A conference call and live webcast to discuss results will follow on November 11, 2026, at 8:30 a.m. Eastern Time. The webcast will be accessible through Azenta's investor website, with a replay available beginning November 12, 2026, at 8:30 a.m. ET.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BURLINGTON, Mass., Oct. 28, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2026 earnings which ended on September 30, 2026, on Tuesday, November 10, 2026, after the market closes.

The Company will host a conference call and live webcast to discuss its financial results the following day, Wednesday, November 11, 2026, at 8:30 a.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on November 12, 2026.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial Planning & Analysis, and Investor Relations
ir@azenta.com

Maria Isabel Cuartas
Manager Investor Relations
ir@azenta.com

Azenta logo

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-announces-fiscal-2026-fourth-quarter-and-full-year-conference-call-and-webcast-302922642.html

SOURCE Azenta

Keep reading